Autres langues Guardant Health, Inc.

Actions

GH

US40131M1099

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
17,35 ^USD	+1,11%		+7,97%	-35,86%

15/04	GUARDANT HEALTH, INC. : Opinion positive de Goldman Sachs	ZM
03/04	Guardant Health présentera des données soulignant l'application de l'épigénomique pour faire progresser l'oncologie de précision lors de l'assemblée annuelle 2024 de l'AACR	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

FDA Advisory Panel Review of Guardant Health's Shield Blood Test to Screen for Colorectal Cancer to Be Held on May 23	23/04
Sector Update: Health Care Stocks Increase Late Afternoon	22/04
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	22/04
Guardant Health Says FDA Advisory Panel Will Review Shield Blood Test for Colorectal Cancer Screening; Shares Rise	22/04
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23	22/04
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024	18/04
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting	03/04
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting	03/04
Guardant Health - Royal Marsden And Guardant Health Partnership Provides State-of-the-art Blood Test To Benefit Lung Cancer Patients In Expanded NHS Study	25/03
50 valores para invertir en IA, salud, movilidad y energía	25/03
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23/03
50 titoli per investire in AI, salute, mobilità ed energia	22/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
Blood test shows 83% accuracy for detecting colorectal cancer in trial	13/03
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine	13/03
Guardant Health, Inc. Announces Results from the ECLIPSE Study Showing the Effectiveness of Its Shield Blood Test for Detecting Colorectal Cancer	13/03
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06/03
Guardant Health, Inc. - New Survey, Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap	04/03
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap	01/03
Guardant Health Q4 Adjusted Loss Narrows as Revenue Rises	23/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Guardant Health, Inc.

Actions

GH

US40131M1099

Autres langues

Filtres